Certificate number:RU.77.99.88.003.Е.003318.02.15 Date of registration and renewal:11.02.2015 Dosage form: & nbspPowder with a mass of 2 g. Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin Food supplements - carbohydrates and products of their processing Classification "Clinical" & nbsp Supplements that support the functions of the immune system Supplements that promote the normalization of lipid metabolism Supplements that support the function of the liver, bile duct and gallbladder Supplements for people who control body weight Supplements that support the functional activity of the thyroid gland BAA, reducing the risk of violations of carbohydrate metabolism BAA to reduce the risk of functional disorders of female cyclic processes Composition: & nbspIngredients: extract of maitake mushroom Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, departments of the trading network as a biologically active food additive - a source of beta-glucans. Suggested Usage: & nbspFor 1 sachet (2 g), dissolve the powder in 1/2 cup (100 ml) of hot water (80 ° C), stir, insist 15 minutes, take the adult once a day with meals. Duration of admission is 1 month. Contraindications:Individual intolerance of components, pregnancy, breast-feeding. Special instructions:Before use, it is recommended to consult a doctor. Shelf life:2 years. Storage conditions:Store in a dry place, protected from light and out of reach of children, at a temperature of no higher than 25 ° C. Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.044517.10.11 of 07.10.2011, the expert opinion of the FBU "Center for Hygiene and Epidemiology in Moscow" No. 12543 dated 07.09.2011, test report "TEST QUALITY "(LLC) №200102 / 15 of 26.01.2015 ManufacturersZhejiang Fangge Pharmaceutical Co., Ltd People's Republic of ChinaZhejiang Fangge Pharmaceutical Co., Ltd., Garden Bridge, Xingguang Road, Songyuan Town, Qingyuan County, Zhejiang Province (People's Republic of China). Recipient:Zhejiang Fangge Pharmaceutical Co., LtdZhejiang Fangge Pharmaceutical Co., Ltd People's Republic of China Information update date: & nbsp22.08.2016 Instructions